LipoScience

About:

LipoScience is pioneering a new field of personalized diagnostics based on nuclear magnetic resonance (NMR) technology.

Top Investors: Invesco, U.S. Bancorp, Piper Sandler, Camden Partners, GE Capital

Description:

LipoScience is pioneering a new field of personalized diagnostics based on nuclear magnetic resonance (NMR) technology. Its first proprietary diagnostic test, the NMR LipoProfile® test, measures the number of low density lipoprotein particles (LDL-P) in a blood sample and provides physicians and their patients with actionable information to personalize management of risk for heart disease. To date, over 8 million NMR LipoProfile tests have been ordered.

Total Funding Amount:

$28M

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

Raleigh, North Carolina, United States

Founded Date:

1994-01-01

Contact Email:

inquiries(AT)liposcience.com

Founders:

James D. Otvos

Number of Employees:

251-500

Last Funding Date:

2006-08-15

IPO Status:

Delisted

Industries: